0460.HK · SIHUAN PHARM
Hong Kong · RS rating 13 · As of 2026-10-14
| Price | 0.71 HKD |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 48 / 16 / 12 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 16 / 17 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +62.8% |
| Market cap (USD) | $859.5M |